Period | Weighting | Quarter | ||||||
---|---|---|---|---|---|---|---|---|
Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 7 | 7 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q2 2024 | 7 |
UBS Group AG | 5 | 1 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q2 2024 | 6 |
Tower Research Capital LLC (TRC) | 6 | 6 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q2 2024 | 6 |
VANGUARD GROUP INC | 6 | 6 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q2 2024 | 6 |
WELLS FARGO & COMPANY/MN | 5 | 5 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2024 | 5 |
TWO SIGMA INVESTMENTS, LP | 3 | 3 | 0.00% | 0.00% | 0.00% | Q4 2023 | Q2 2024 | 3 |
GEODE CAPITAL MANAGEMENT, LLC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q4 2023 | Q2 2024 | 3 |
SABBY MANAGEMENT, LLC | 3 | 3 | 0.10% | 0.18% | 0.28% | Q4 2023 | Q2 2024 | 3 |
Citadel Advisors | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q1 2024 | 2 |
FMR LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2024 | 2 |
HRT FINANCIAL LP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2024 | Q1 2024 | 1 |
TWO SIGMA SECURITIES, LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 |
BANK OF AMERICA CORP /DE/ | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2024 | Q2 2024 | 1 |
This page lists all the filers that currently own LIPELLA PHARMACEUTICALS INC or have owned LIPELLA PHARMACEUTICALS INC in the past.